Why the Lone EpiPen Competitor Hasn’t Taken Off
Tuesday, November 1, 2016 - 23:31
in Mathematics & Economics
Adrenaclick, a cheaper alternative, has benefited from furor over EpiPen pricing. But its maker is struggling to meet demand, and a generic EpiPen is near.